← Leaderboards
Hirohito Kita
Mayo Clinic Arizona
$28,292,081
Attributed
$33,397,635
Total exposure
14
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,834,937 · 15
By mechanism
R01$25,412,947 · 7
R37$4,655,313 · 1
P01$4,437,302 · 2
T32$1,739,686 · 1
R56$1,345,759 · 3
R34$243,930 · 1
Top collaborators
- Scott M. O'Grady17 shared
Most similar at Mayo Clinic Arizona
Same institution · by research overlap
- Scott M. O'Grady$5,999,588
- Thomas E Grys$288,447
Others in their field
Top investigators on “Cytokine”
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$83,965,880
- David Heimbrook · Leidos Biomedical Research, Inc.$56,453,265
- Fulton T Crews · University Of North Carolina Chapel Hill$36,249,590
- Marianne Ward · Duke University$34,872,957
- Joren C Madsen · Massachusetts General Hospital$33,058,731
- Barton F Haynes · Duke University$29,068,807
Research focus
CytokineAsthmaImmune ResponseCellsProductionImmunityImmuneInflammationResponseExposure ToAirborne AllergenMediatingAlternariaIn VitroMouse ModelAirway InflammationGrantAllergensPlayAllergicCollaborationsPathway InteractionsPreventImmunologics
Grant awards (90)
Allergen-induced extracellular DNA in type 2 immunity$1,247,804
R01 · FY2025 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$582,546
R01 · FY2025 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$578,582
R37 · FY2025 · AI · contact PI
Allergen-induced extracellular DNA in type 2 immunity$631,168
R01 · FY2024 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$604,553
R01 · FY2024 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$578,847
R37 · FY2024 · AI · contact PI
Roles of Group 2 Innate Lymphoid Cells in Asthma$298,291
R56 · FY2024 · AI · contact PI
Allergen-induced extracellular DNA in type 2 immunity$635,887
R01 · FY2023 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$609,009
R01 · FY2023 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$595,729
R37 · FY2023 · AI · contact PI
Allergen-induced extracellular DNA in type 2 immunity$649,135
R01 · FY2022 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$630,120
R01 · FY2022 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$486,478
R37 · FY2022 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$516,518
R01 · FY2021 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$493,711
R37 · FY2021 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$473,302
R01 · FY2021 · HL · contact PI
Mechanisms of IL-33 secretion in allergic diseases$521,369
R01 · FY2020 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$512,958
R37 · FY2020 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$491,326
R01 · FY2020 · HL · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$409,223
R37 · FY2020 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$510,759
R01 · FY2019 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$472,199
R01 · FY2019 · HL · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$265,145
R37 · FY2019 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$231,315
R37 · FY2019 · AI · contact PI
Mechanisms of IL-33 secretion in allergic diseases$509,737
R01 · FY2018 · AI · contact PI
Mechanisms of Allergen-induced Type 2 Immunity$503,325
R37 · FY2018 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$487,964
R01 · FY2018 · HL · contact PI
Mechanisms of IL-33 secretion in allergic diseases$522,735
R01 · FY2017 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$394,691
R01 · FY2017 · HL · contact PI
Alternaria and ribonucleases in Th2-type immunity$382,656
R01 · FY2017 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$394,691
R01 · FY2016 · HL · contact PI
Alternaria and ribonucleases in Th2-type immunity$384,229
R01 · FY2016 · AI · contact PI
Training Grant in Allergic Diseases$124,895
T32 · FY2016 · AI · contact PI
Alternaria and ribonucleases in Th2-type immunity$535,742
R01 · FY2015 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$388,770
R01 · FY2015 · HL · contact PI
Training Grant in Allergic Diseases$177,040
T32 · FY2015 · AI · contact PI
Allergen-induced IL-33 release by the airway epithelium$501,983
R01 · FY2014 · HL · contact PI
Alternaria and ribonucleases in Th2-type immunity$467,050
R01 · FY2014 · AI · contact PI
Type 2 Innate Lymphoid Cells and Asthma$395,813
R01 · FY2014 · HL · contact PI
Training Grant in Allergic Diseases$173,701
T32 · FY2014 · AI · contact PI
Allergen-induced IL-33 release by the airway epithelium$489,506
R01 · FY2013 · HL · contact PI
Alternaria and ribonucleases in Th2-type immunity$380,030
R01 · FY2013 · AI · contact PI
Training Grant in Allergic Diseases$178,867
T32 · FY2013 · AI · contact PI
Allergen-induced IL-33 release by the airway epithelium$516,032
R01 · FY2012 · HL · contact PI
Mechanisms of Eosinophilic Inflammation in Human Disease$396,886
R56 · FY2012 · AI · contact PI
Alternaria and proteases in innate and adaptive Th2 immunity$373,254
R01 · FY2012 · AI · contact PI
The Pathogenesis of Chronic Rhinosinusitis$278,281
R56 · FY2012 · AI · contact PI
Training Grant in Allergic Diseases$113,538
T32 · FY2012 · AI · contact PI
Allergen-induced IL-33 release by the airway epithelium$532,247
R01 · FY2011 · HL · contact PI
The Pathogenesis of Chronic Rhinosinusitis$487,845
R01 · FY2011 · AI · contact PI
Alternaria and proteases in innate and adaptive Th2 immunity$373,430
R01 · FY2011 · AI · contact PI
The Pathogenesis of Chronic Rhinosinusitis$483,395
R01 · FY2010 · AI · contact PI
Mechanisms Of Eosinophil Degranulation in Human Disease$348,920
R01 · FY2010 · AI · contact PI
Alternaria and proteases in innate and adaptive Th2 immunity$339,625
R01 · FY2010 · AI · contact PI
Training Grant in Allergic Diseases$180,278
T32 · FY2010 · AI · contact PI
The Pathogenesis of Chronic Rhinosinusitis$478,487
R01 · FY2009 · AI · contact PI
Alternaria and proteases in innate and adaptive Th2 immunity$377,505
R01 · FY2009 · AI · contact PI
Mechanisms Of Eosinophil Degranulation in Human Disease$352,444
R01 · FY2009 · AI · contact PI
Training Grant in Allergic Diseases$127,883
T32 · FY2009 · AI · contact PI
The Pathogenesis of Chronic Rhinosinusitis$468,781
R01 · FY2008 · AI · contact PI
Alternaria and proteases in innate and adaptive Th2 immunity$390,142
R01 · FY2008 · AI · contact PI
Mechanisms Of Eosinophil Degranulation in Human Disease$352,444
R01 · FY2008 · AI · contact PI
Training Grant in Allergic Diseases$180,267
T32 · FY2008 · AI · contact PI
The Pathogenesis of Chronic Rhinosinusitis$477,365
R01 · FY2007 · AI · contact PI
Mechanisms Of Eosinophil Degranulation in Human Disease$359,270
R01 · FY2007 · AI · contact PI
Planning a Multicenter Oral Itraconazole Trial in Chronic Rhinosinusitis Patients$243,930
R34 · FY2007 · AI · contact PI
Training Grant in Allergic Diseases$123,708
T32 · FY2007 · AI · contact PI
Mechanisms Of Eosinophil Degranulation in Human Disease$370,000
R01 · FY2006 · AI · contact PI
Training Grant in Allergic Diseases$24,952
T32 · FY2006 · AI · contact PI
Mechanisms of Eosinophilic Inflammation in Human Asthma$961,252
P01 · FY2005 · AI
Pathogenesis of Chronic Rhinosinusitis$451,056
R01 · FY2005 · AI
Mechanisms Of Eosinophil Degranulation In Human Disease$372,301
R56 · FY2005 · AI
Mechanisms of Eosinophilic Inflammation in Human Asthma$933,628
P01 · FY2004 · AI
Pathogenesis of Chronic Rhinosinusitis$438,591
R01 · FY2004 · AI
MECHANISMS OF EOSINOPHIL DEGRANULATION IN HUMAN DISEASE$293,876
R01 · FY2004 · AI
TRAINING GRANT IN ALLERGIC DISEASES$180,467
T32 · FY2004 · AI
Mechanisms of Eosinophilic Inflammation in Human Asthma$906,806
P01 · FY2003 · AI
Pathogenesis of Chronic Rhinosinusitis$426,492
R01 · FY2003 · AI
MECHANISMS OF EOSINOPHIL DEGRANULATION IN HUMAN DISEASE$285,317
R01 · FY2003 · AI
TRAINING GRANT IN ALLERGIC DISEASES$69,435
T32 · FY2003 · AI
Mechanisms of Eosinophilic Inflammation in Human Asthma$767,879
P01 · FY2002 · AI
Pathogenesis of Chronic Rhinosinusitis$414,744
R01 · FY2002 · AI
MECHANISMS OF EOSINOPHIL DEGRANULATION IN HUMAN DISEASE$277,008
R01 · FY2002 · AI
TRAINING GRANT IN ALLERGIC DISEASES$84,655
T32 · FY2002 · AI
Eosinophilic inflammation in intrinsic asthma$0
P01 · FY2002 · AI
Mechanisms of Eosinophilic Inflammation in Human Asthma$867,737
P01 · FY2001 · AI
Pathogenesis of Chronic Rhinosinusitis$403,339
R01 · FY2001 · AI
MECHANISMS OF EOSINOPHIL DEGRANULATION IN HUMAN DISEASE$268,939
R01 · FY2001 · AI
Eosinophilic inflammation in intrinsic asthma$0
P01 · FY2001 · AI
MECHANISMS OF EOSINOPHIL DEGRANULATION IN HUMAN DISEASE$261,107
R01 · FY2000 · AI